Timothy Luschen
Physician Assistant · Warner Robins, GANPI 1245281989
Payments from drug & device makers
Across 272 payments — averaging $20.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$854
- Novo Nordisk$816
- Bayer$429
- GSK$287
- Takeda Pharmaceuticals U.S.A., Inc.$215
- Amgen$192
- plus $3K from 32 others
What the payments were for
- Food & beverage$5,29497%
- Education$1553%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $854 |
| Novo Nordisk | 40 | $816 |
| Bayer | 23 | $429 |
| GSK | 17 | $287 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $215 |
| Amgen | 9 | $192 |
| AstraZeneca(2 entities) | 9 | $182 |
| Boehringer Ingelheim | 10 | $181 |
| Lilly USA, LLC | 11 | $177 |
| Grifols USA, LLC | 7 | $171 |
| Sanofi | 6 | $163 |
| Harmony Biosciences LLC | 3 | $156 |
| Antares Pharma, Inc. | 7 | $149 |
| ANI Pharmaceuticals, Inc. | 6 | $146 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $128 |
| Xeris Pharmaceuticals, Inc. | 6 | $118 |
| Amarin Pharma, Inc. | 6 | $110 |
| Insmed, Inc. | 5 | $110 |
| Pfizer | 5 | $87 |
| Sanofi-aventis U.S. LLC | 1 | $85 |
| Novartis | 5 | $83 |
| Advanced Respiratory, Inc | 4 | $81 |
| Biohaven Pharmaceuticals, Inc. | 4 | $75 |
| Teva Pharmaceuticals USA, Inc. | 4 | $63 |
| United Therapeutics Corporation | 3 | $61 |
| Abbott | 2 | $45 |
| Baxter Healthcare | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $35 |
| Exact Sciences | 2 | $30 |
| Arbor Pharmaceuticals, Inc. | 2 | $30 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| Insulet Corporation | 1 | $25 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $22 |
| Shield Therapeutics Inc | 1 | $20 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| IBSA Pharma Inc. | 1 | $14 |
| Dexcom, Inc. | 1 | $14 |
How this compares
$5,449 in reported general payments places this provider in the 90th percentile of 3,581 physician assistant providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tresiba Flextouch U-200Insulin Degludec | 31 | $69,225 |
| JardianceEmpagliflozin | 50 | $54,745 |
| KerendiaFinerenone | 28 | $30,428 |
| CreonLipase/Protease/Amylase | 11 | $29,296 |
| EliquisApixaban | 31 | $25,245 |
| Spiriva RespimatTiotropium Bromide | 18 | $24,494 |
| OzempicSemaglutide | 26 | $21,968 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $19,739 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 33 | $19,453 |
| MyrbetriqMirabegron | 22 | $16,253 |
| JanuviaSitagliptin Phosphate | 23 | $15,044 |
| VascepaIcosapent Ethyl | 24 | $13,469 |
| Tresiba Flextouch U-100Insulin Degludec | 16 | $9,771 |
| RybelsusSemaglutide | 13 | $8,482 |
| TrintellixVortioxetine Hydrobromide | 12 | $8,369 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Spiriva Respimat, Stiolto Respimat | $181 | $98,692101 claims |
| AbbVieCreon, Synthroid | $854 | $35,13472 claims |
| Novo NordiskOzempic, Rybelsus | $816 | $30,45039 claims |
| BayerKerendia | $429 | $30,42828 claims |
| PfizerEliquis | $87 | $25,24531 claims |
| GSKTrelegy Ellipta | $287 | $19,73918 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $215 | $8,36912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,581 physician assistant providers in Georgia.
Other physician assistant in Warner Robins
- Douglas DiruggieroCartersville$1.3M
- Jennifer CobbsAtlanta$1M
- A BrunnerStockbridge$1M
- Joseph LangshawCalhoun$887K
- Alison MoeAtlanta$410K
- Maggie SchreckAtlanta$389K
- Lisa HillMarietta$190K
- Laura BishopBrunswick$103K
- Jaime AckermanAtlanta$84K
- Richard BurrellBrunswick$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.